CN107582805A - One kind controls beriberi - Google Patents

One kind controls beriberi Download PDF

Info

Publication number
CN107582805A
CN107582805A CN201710978962.8A CN201710978962A CN107582805A CN 107582805 A CN107582805 A CN 107582805A CN 201710978962 A CN201710978962 A CN 201710978962A CN 107582805 A CN107582805 A CN 107582805A
Authority
CN
China
Prior art keywords
parts
bulk drug
beriberi
radix
foot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710978962.8A
Other languages
Chinese (zh)
Inventor
赖宁宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University for Nationalities
Original Assignee
Guangxi University for Nationalities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University for Nationalities filed Critical Guangxi University for Nationalities
Priority to CN201710978962.8A priority Critical patent/CN107582805A/en
Publication of CN107582805A publication Critical patent/CN107582805A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to one kind to control beriberi medicament, and it is made up of the bulk drug of following weight:20 parts of cape jasmine 10 part, 30 parts of toddalia 10 part, 15 parts of bitter orange 10 part, 15 25 parts of Radix Liriopes, 20 parts of asarum 10 part, windproof 15 parts 25 parts, 25 parts of the root of Dahurain angelica 10 part, 30 parts of radix aconiti agrestis 20 part, 20 parts of Radix Angelicae Sinensis 10 part, 30 parts of Ligusticum wallichii 10 part, 20 parts of peppermint 10 part, 30 parts of frankincense 20 part.The beneficial effects of the invention are as follows:Bulk drug wide material sources, it is cheap and be easy to buy, foot fungi can be reduced and produced, fungal infection can be eliminated, can treating beriberi, have analgesic effect, it can prevent that patient from being rubbed foot due to pain, the skin for avoiding patient is ruptured due to friction, avoids fungal infection, tinea pedis can quickly be removed, reduce treatment time, therapeutic process can be shortened, therapeutic effect is obvious, cure rate is high, uneasy to recur.

Description

One kind controls beriberi
Technical field
The invention belongs to field of medicaments, especially one kind to control beriberi.
Background technology
Tinea pedis is a kind of common fungal infectious disease, and 70%-80% people has tinea pedis in adult, and weight is different, leads to Often aggravate, mitigate in the winter time, also someone is not cured throughout the year in summer.The pathogenesis of tinea pedis is:Tinea pedis is by contagion.Due to The palm, plantar epidermal cell substitute time length, and cutin thickness, sweat gland is more, and without sebaceous glands, and biped often wears footgear, it is close not Ventilative, sweat evaporation is difficult, is allowed to local temperature height, high humidity, cuticula often impregnated softening, the change of epidermis acid-base value, satisfies Good condition is created for fungi growth.In addition, personal hygiene custom is bad, contact the footgear of patient, gloves, share slippers, Towel and bathing pool etc., then it is easy to be infected.Dermatophyte is usually through the publilc baths of the pollution, floor of edge of pool, bath towel, public Slippers, foot basin and infect.The pathogenic factor of tinea pedis is:Pathogenic bacteria polyphyly trichophyton and Epidermophyton kind, main bacteria seed have Trichophyton rubrum, trichophyton gypseum, acrothesium floccosum, trichophyton meginii.Trichophyton rubrum is not easy because its resistance is strong Control, it has also become the Main Pathogenic Bacteria of the current tinea pedis in China.
The harm of tinea pedis is:
1. tinea pedis can cause acute lymphangitis, simply a kind of common inflammation, when macerative erosive either vesicle Beriberi infection suppurate when be easy to cause acute lymphangitis.
2. tinea pedis causes erysipelas, so-called erysipelas is exactly a kind of inflammation caused by tinea pedis, and the traditional Chinese medical science is referred to as filariasis, and patient is past It is hurried toward onset, patient is cold, heating, nausea etc. symptom, body temperature may be to 39 degree, leucocyte raises.Lighter patient is only There is transient erythema in ankle and foot skin, a few patients may occur in which local tissue necrosis.Elderly and infirm, kidney can also occur The complication such as scorching, subcutaneous abscess and septicemia.
3. celluar tissue, this is also one of inflammation caused by tinea pedis, and general disease hair removes to be removed for the illness of tinea pedis, the ground of infection Square soft tissue is loose, and inflammation can spread to surrounding, or even can feed through to the tissue in deep, reach osseous part, can draw when serious Play blister.Generally, abscess occurs in celluar tissue within the time of one week, can also cause angioleucitis and sepsis Disease.
The medicine that in the market is used to treat tinea pedis has a lot, but these common medicine general therapeutic effects are poor, control More rate is relatively low, treatment time length, easy recurrent exerbation.
The content of the invention
The shortcomings that present invention is directed to above-mentioned prior art, there is provided one kind controls beriberi, and cost is low, and therapeutic effect is obvious, Treatment time is short, and cure rate is high, and therapeutic effect is thorough, uneasy to recur.
The present invention solves the technical scheme that its technical problem uses:This medicine for controlling tinea pedis, it is characterised in that it be by The bulk drug of following weight is made:10 parts -20 parts of cape jasmine, 10 parts -30 parts of toddalia, 10 parts -15 parts of bitter orange, mountain wheat 15 parts -25 parts of winter, 10 parts -20 parts of asarum, windproof 15 parts -25 parts, 10 parts -25 parts of the root of Dahurain angelica, 20 parts -30 parts of radix aconiti agrestis, 10 parts of Radix Angelicae Sinensis - 20 parts, 10 parts -30 parts of Ligusticum wallichii, 10 parts -20 parts of peppermint, 20 parts -30 parts of frankincense.
The dosage of above-mentioned each bulk drug is that it is made up of the bulk drug of following weight:15 parts of cape jasmine, the flying dragon palm 20 parts of blood, 15 parts of bitter orange, 20 parts of Radix Liriopes, 18 parts of asarum, windproof 22 parts, 16 parts of the root of Dahurain angelica, 16 parts of radix aconiti agrestis, 18 parts of Radix Angelicae Sinensis, Ligusticum wallichii 24 parts, 18 parts of peppermint, 30 parts of frankincense.
The preparation method of this medicine is:Weighed by the bulk drug of above-mentioned weight, mixing is smashed to pieces, mixed after smashing to pieces Close bulk drug to insert in marmite, 2000 grams -3000 grams of water is added in marmite, it is small that 2 are decocted at a temperature of 70 DEG C~90 DEG C When -4 hours, the juice of bulk drug is obtained after filtering, is produced after its cooling and controls beriberi.
Cape jasmine:Property it is bitter, cold, have purging intense heat and detonicating, clearing heat and promoting diuresis, cool blood dissipates the stasis of blood, to treatment tinea pedis have special result;
Toddalia:Toddalia has dissipate stasis of blood hemostasis, dispelling wind and eliminating dampness, the effect of subdhing swelling and detoxicating;
Bitter orange:Property bitter, temperature, there is the effect of qi-regulating;
Radix Liriopes:It is slightly cold, is sweet, slight bitter, the effect with nourishing Yin and promoting production of body fluid;
Asarum:It is warm-natured, pungent, there is expelling wind and clearing away cold, sensible analgesic, the effect of Wenfei of drink;
It is windproof:It is tepor, pungent, sweet, have that inducing diaphoresis to dispel wind, victory be wet, effect of only convulsion;
The root of Dahurain angelica:It is warm-natured, pungent, have and dissipate wind dehumidifying, sensible analgesic, the effect of detumescence and apocenosis;
Radix aconiti agrestis:Property it is hot, pungent, bitter, have dispelling wind and eliminating dampness, the effect of antalgic;
Radix Angelicae Sinensis:It is warm-natured, sweet, pungent, there is replenishing and activating blood, the effect of menstruction regulating and pain relieving;
Ligusticum wallichii:It is warm-natured, pungent, there is blood-activating and qi-promoting, the effect of wind-expelling pain-stopping;
Peppermint:Cool in nature, good fortune, has the effect of fine to diseases such as skin rubella itching, measless without adequate eruption,
In addition it is also effective to carbuncle, subcutaneous ulcer, scabies, tinea, dermatitis rhus;
Frankincense:It is warm-natured, pungent, bitter, there is blood-activating and qi-promoting analgesic, the effect of detumescence and promoting granulation.
The bulk drug that the present invention selects, there is the effect invigorating blood circulation, stop blooding, enriching blood, beneficial to foot's vim and vigour circulation, supplement foot Qi and blood, the activity of increase foot cell, beneficial to Skin Cell activity, reduce fungi and produce;The bulk drug that the present invention selects, has Subdhing swelling and detoxicating, dispelling wind and eliminating dampness, the fungi activity of foot can be eliminated, protects foot's skin by fungal infection, not reduce and infect;This hair The bulk drug of bright selection, there is the effect of analgesic, patient's friction foot can be prevented, avoid skin from fraying, reduce fungal infection.
The beneficial effects of the invention are as follows:Bulk drug wide material sources, it is cheap and be easy to buy, foot fungi can be reduced Produce, fungal infection can be eliminated, can treating beriberi, have analgesic effect, can prevent patient from being rubbed due to pain Foot, the skin for avoiding patient are ruptured due to friction, avoid fungal infection, can quickly be removed tinea pedis, be reduced and control The time is treated, therapeutic process can be shortened, therapeutic effect is obvious, and cure rate is high, uneasy to recur.

Claims (3)

1. one kind controls beriberi, it is characterised in that it is made up of the bulk drug of following weight:10 part -20 of cape jasmine It is part, 10 parts -30 parts of toddalia, 10 parts -15 parts of bitter orange, 15 parts -25 parts of Radix Liriopes, 10 parts -20 parts of asarum, windproof 15 part -25 Part, 10 parts -25 parts of the root of Dahurain angelica, 20 parts -30 parts of radix aconiti agrestis, 10 parts -20 parts of Radix Angelicae Sinensis, 10 parts -30 parts of Ligusticum wallichii, 10 parts -20 parts of peppermint, frankincense 20 parts -30 parts.
2. according to claim 1 control beriberi, it is characterised in that it is by the bulk drug system of following weight Into:15 parts of cape jasmine, 20 parts of toddalia, 15 parts of bitter orange, 20 parts of Radix Liriopes, 18 parts of asarum, windproof 22 parts, 16 parts of the root of Dahurain angelica, radix aconiti agrestis 16 parts, 18 parts of Radix Angelicae Sinensis, 24 parts of Ligusticum wallichii, 18 parts of peppermint, 30 parts of frankincense.
3. the preparation method according to claim 1 or 2 for controlling beriberi, it is characterised in that:By above-mentioned weight Bulk drug weigh, mixing is smashed to pieces, and the mixed material medicine after smashing to pieces is inserted in medicine pot, in marmite add 2000 gram -3000 Gram water, decocted -4 hours 2 hours at a temperature of 70 DEG C~90 DEG C, the juice of bulk drug obtained after filtering, after its cooling after Produce and control beriberi.
CN201710978962.8A 2017-10-19 2017-10-19 One kind controls beriberi Pending CN107582805A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710978962.8A CN107582805A (en) 2017-10-19 2017-10-19 One kind controls beriberi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710978962.8A CN107582805A (en) 2017-10-19 2017-10-19 One kind controls beriberi

Publications (1)

Publication Number Publication Date
CN107582805A true CN107582805A (en) 2018-01-16

Family

ID=61053648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710978962.8A Pending CN107582805A (en) 2017-10-19 2017-10-19 One kind controls beriberi

Country Status (1)

Country Link
CN (1) CN107582805A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111700965A (en) * 2020-08-09 2020-09-25 仲崇允 A Chinese medicinal external preparation for treating fungal infection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615568B1 (en) * 2003-08-26 2007-04-12 한상룡 composite of including pyroligneous acid and peppermint oil for skin disease and method of making the same
CN103263564A (en) * 2013-04-24 2013-08-28 景宁畲艺坊服饰有限公司 Drug for treating dermatophytosis
CN103961539A (en) * 2014-05-16 2014-08-06 湖州康企药业有限公司 Medicament for treating dermatophytosis
CN104147584A (en) * 2014-09-07 2014-11-19 吴俊� Medicine for treating beriberi and manufacturing method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615568B1 (en) * 2003-08-26 2007-04-12 한상룡 composite of including pyroligneous acid and peppermint oil for skin disease and method of making the same
CN103263564A (en) * 2013-04-24 2013-08-28 景宁畲艺坊服饰有限公司 Drug for treating dermatophytosis
CN103961539A (en) * 2014-05-16 2014-08-06 湖州康企药业有限公司 Medicament for treating dermatophytosis
CN104147584A (en) * 2014-09-07 2014-11-19 吴俊� Medicine for treating beriberi and manufacturing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
会员101382111: "去年脚上长了脚气用干薄荷泡水治好了,今年...", 《寻医问药,HTTP://CLUB.XYWY.COM/STATIC/20160712/112419581.HTM》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111700965A (en) * 2020-08-09 2020-09-25 仲崇允 A Chinese medicinal external preparation for treating fungal infection

Similar Documents

Publication Publication Date Title
CN103142953A (en) Foot-bath health-protective Chinese medicament powder
JP4302534B2 (en) Dermatitis treatment lotion
CN109364226A (en) A kind of active relaxing muscles and tendons of moisturizing is releived the ancient method plants essential oil ached and preparation method
CN104523969A (en) Medicine for treating arthromyodynia due to kidney-yang deficiency
CN104208245B (en) Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method
CN107998349A (en) A kind of external application mud moxibustion and preparation method thereof
CN102920802A (en) Foot bath prescription for home health care
KR20110138459A (en) Herb medicine composition
CN100566702C (en) Liquid medicine in the health care of a kind of bath foot
CN107582805A (en) One kind controls beriberi
CN104983928A (en) Steam-bath health steaming medical package containing agilawood
CN103520690A (en) Foot bathing powder for relaxing muscles and joints, dredging collaterals and reducing pressure
CN105561270A (en) Analgesic Chinese herbal medicine for external application and preparation method thereof
CN105616653A (en) Traditional Chinese medicine composition for treating prickly heat
CN105616643A (en) Traditional Chinese medicinal treatment liquid for treating erosive psoriasis
CN103520687A (en) Bath foot powder for inhibiting fungi
CN103263564B (en) Drug for treating dermatophytosis
CN102755530B (en) Traditional Chinese medicine composition for treating diabetic foot and application thereof
CN102949483A (en) Foot-bath liquid for moistening lung and beautifying
CN102949466A (en) Foot bathing liquid for yang promotion and solid doff
CN107951930A (en) It is a kind of to be used to treat spray of allergic rhinitis and preparation method thereof
CN102824456A (en) Specific medicine for treating animal aftosa
CN102441096B (en) Disperse blood stasis and dredge collateral compound recipe pill and preparation method thereof
CN110179956B (en) Traditional Chinese medicine external lotion for treating hyperhidrosis erosive beriberi
CN107096017A (en) Treat dermopathic external medicine composition and its application method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180116

WD01 Invention patent application deemed withdrawn after publication